The product formulation has been subject to a series of extensive independent tests to demonstrate its ability to eliminate a wide variety of pathogens, it has also been subject to full biocompatibility testing according to the internationally recognised ISO 10993 series of standards. These include tests for cytotoxicity, irritation and skin sensitization. As a result, Spectricept in the form that we are applying as a biocide is classified as non-toxic, non-irritant, non-mutagenic, non-haemolytic, non-pyrogenic and non-sensitizing. Crucially, having created a HOCl substance with an extended shelf life we have the supply and the ability to deploy this solution at scale. The solution is odourless and behaves like water, which constitutes 99.94% of its volume.
Another key feature of HOCl includes its ability to pose non-selective or wide spectrum antiviral and antibacterial effects against a broad range of viruses and bacteria, without inducing drug-resistance. HOCl does not rely on a single mode of action to block or eradicate viruses and bacteria – studies to date have shown its activity against pathogens, because of its broad-spectrum non-specific activity, does not induce resistance amongst target viruses and bacteria.